Progenity is now offering PCR testing for SARS-CoV2

November 2020

To support the need for accurate COVID-19 testing in the US, Progenity is now offering COVID-19 PCR testing through its affiliate, Avero Diagnostics.

With flexible specimen collection options, simple test ordering, clear results, fast turnaround times, and reasonable testing costs, we’re here to help you identify more infected patients and provide proper patient management in the pandemic.

Gold-standard PCR testing

RT-PCR assay for SARS-CoV2 detects the viral genetic material (viral RNA) that is present in the body.

Determines whether the patient has an active COVID-19 infection, potentially before symptoms of the disease are present.

More than 30,000 tests performed to date by our CLIA-licensed and CAP-certified laboratory under Emergency Use Authorization (EUA) by the FDA.

Flexible specimen collection

Nasal, nasopharyngeal, and oropharyngeal swab specimens accepted; stable for 3 days at room temperature.

24 – 48 hour turnaround time; to date, 97% of specimens reported within 24 hours of receipt.

CDC-required state reporting performed for all COVID-19 testing (currently offered in all states except CA and NY).

Reasonable testing cost

Thanks to the Families First Coronavirus Response Act (FFCRA), many people will have no out-of-pocket cost when testing is deemed medically appropriate by the healthcare provider.

All testing is healthcare provider directed and requires a provider signature on the test requisition form.

Cost of testing is $100 – either billed to insurance or self-pay.

Resources

As always, the health and well-being of our clients, employees, and community is our top priority. Please reach out to your local Progenity representative, or our Client Services team at +1 855-293-2639 with any questions.

Support